During 2018 Q3 the big money sentiment increased to 1.22. That’s change of 0.11, from 2018Q2’s 1.11. 34 investors sold all, 83 reduced holdings as Patterson Companies, Inc. ratio increased. 95 increased holdings while 48 funds amassed holdings. Funds hold 91.24 million shares thus 4.08% less from 2018Q2’s 95.11 million shares.
California State Teachers Retirement Systems owns 131,891 shs. Element Capital Mgmt Limited Liability accumulated 0.01% or 11,282 shs. Glenmede Trust Na invested 0% in Patterson Companies, Inc. (NASDAQ:PDCO). 629,042 are held by Alyeska Investment Ltd Partnership. Parkside Finance Fincl Bank owns 498 shs for 0% of their capital. Comerica Bank & Trust owns 53,205 shs or 0.01% of their US capital. Ing Groep Nv accumulated 0.01% or 12,615 shs. Price T Rowe Assoc Md invested in 0.04% or 11.17M shs. Metropolitan Life Company New York reported 0.01% in Patterson Companies, Inc. (NASDAQ:PDCO). Australia-based Macquarie Gru Ltd has invested 0% in Patterson Companies, Inc. (NASDAQ:PDCO). The Michigan-based Plante Moran Advsrs Ltd Com has invested 0.01% in Patterson Companies, Inc. (NASDAQ:PDCO). Qs Invsts Limited Company reported 4,555 shs. Kwmg Ltd holds 0% or 114 shs. Geode Capital Management Ltd Llc accumulated 1.16 million shs. Kentucky-based Teachers Retirement Sys Of The State Of Kentucky has invested 0% in Patterson Companies, Inc. (NASDAQ:PDCO).
Patterson Companies, Inc. (NASDAQ:PDCO) Ratings Coverage
In total 5 analysts cover Patterson Companies (NASDAQ:PDCO). “Buy” rating has 0, “Sell” are 2, while 3 are “Hold”. (NASDAQ:PDCO) has 0 bullish analysts. 5 are the (NASDAQ:PDCO)’s ratings reports on Feb 2, 2019 according to StockzIntelligence Inc. In Friday, August 31 report Morgan Stanley maintained the stock with “Underweight” rating. The stock rating was maintained by Barclays Capital with “Underweight” on Friday, August 31. On Thursday, January 3 the firm has “In-Line” rating by Evercore given. Listed here are Patterson Companies, Inc. (NASDAQ:PDCO) PTs and latest ratings.
17/01/2019 Broker: UBS Rating: Neutral New Target: $23 Initiates Coverage On
03/01/2019 Broker: Evercore Old Rating: Underperform New Rating: In-Line Upgrade
31/08/2018 Broker: Morgan Stanley Old Rating: Underweight New Rating: Underweight Old Target: $21 New Target: $19 Maintain
31/08/2018 Broker: Barclays Capital Old Rating: Underweight New Rating: Underweight Old Target: $23 New Target: $20 Maintain
10/08/2018 Broker: Leerink Swann Rating: Market Perform New Target: $25 Initiates Coverage On
PDCO is reaching $22.36 during the last trading session, after increased 0.31%.Patterson Companies, Inc. has volume of 809,570 shares. Since February 2, 2018 PDCO has declined 35.98% and is downtrending. PDCO underperformed the S&P500 by 35.98%.
Patterson Companies, Inc. distributes and sells dental and animal health products in the United States, the United Kingdom, and Canada.The firm is valued at $2.09 billion. It operates through Dental and Animal Health divisions.13.47 is the P/E ratio. The companyÂ’s Dental segment offers consumable products, such as infection control, restorative materials, hand instruments, and sterilization products; basic and advanced technology dental equipment; patient education systems; and office forms and stationery.
For more Patterson Companies, Inc. (NASDAQ:PDCO) news posted briefly go to: Seekingalpha.com, Nasdaq.com, Nasdaq.com, Nasdaq.com or Seekingalpha.com. The titles are as follows: “Patterson Companies Is Worth A Look – Seeking Alpha” posted on July 23, 2018, “Pre-Market Earnings Report for December 6, 2018 : KR, TTC, THO, MIK, SIG, PLCE, PDCO, MEI, DLTH, GCO, FGP – Nasdaq” on December 04, 2018, “Why Is Patterson Cos. (PDCO) Down 11% Since Last Earnings Report? – Nasdaq” with a publish date: January 05, 2019, “Ex-Dividend Reminder: Patterson Companies, Waddell & Reed Financial and Science Applications International – Nasdaq” and the last “Patterson Companies: Should You Buy This Medical Supplier’s 4.2% Yield? – Seeking Alpha” with publication date: June 28, 2018.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.